|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: TRANSKARYOTIC THERAPIES INC, 10-Q, EX-10.37, 2000-08-14 |
Next: WILSON BANK HOLDING CO, 10-Q, 2000-08-14 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<RESTATED>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 193,797
<SECURITIES> 73,668
<RECEIVABLES> 0
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 1,793
<PP&E> 34,432
<DEPRECIATION> 12,666
<TOTAL-ASSETS> 291,303
<CURRENT-LIABILITIES> 8,634
<BONDS> 10,500
0
1
<COMMON> 227
<OTHER-SE> 271,941
<TOTAL-LIABILITY-AND-EQUITY> 291,303
<SALES> 0
<TOTAL-REVENUES> 1,514
<CGS> 0
<TOTAL-COSTS> 16,655
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (12,220)
<INCOME-TAX> 0
<INCOME-CONTINUING> (12,220)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (12,220)
<EPS-BASIC> (.54)
<EPS-DILUTED> (.54)
</TABLE>
|
|